Follow
Freja Albjerg Venning
Freja Albjerg Venning
UCB Nordic
Verified email at ucb.com - Homepage
Title
Cited by
Cited by
Year
Targeting ECM disrupts cancer progression
FA Venning, L Wullkopf, JT Erler
Frontiers in oncology 5, 224, 2015
2822015
ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix
AE Mayorca-Guiliani, CD Madsen, TR Cox, ER Horton, FA Venning, ...
Nature medicine 23 (7), 890-898, 2017
1642017
Hypoxia and loss of PHD 2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis
CD Madsen, JT Pedersen, FA Venning, LB Singh, E Moeendarbary, ...
EMBO reports 16 (10), 1394-1408, 2015
1482015
Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer
FA Venning, KW Zornhagen, L Wullkopf, J Sjölund, C Rodriguez-Cupello, ...
Journal of Experimental & Clinical Cancer Research 40 (1), 175, 2021
252021
Targeting ECM disrupts cancer progression. Front Oncol 5: 224
FA Venning, L Wullkopf, JT Erler
102015
The carcinogenic agent azoxymethane (AOM) enhances early inflammation-induced colon crypt pathology
FA Venning, MH Claesson, H Kissow
J Cancer Sci Ther 5 (11), 377-383, 2013
102013
Enteroantigen (eAg)‐binding B lymphocytes in the mouse–phenotype, distribution, function and eAg‐specific antibody secretion
FA Venning, ML Trempenau, E Schmidt, MH Claesson
Apmis 122 (7), 616-627, 2014
42014
Heterogeneity of cancer-associated fibroblasts: Metastatic potential and time determine CAF population composition
FA Venning, KW Zornhagen, T Thurison, CD Madsen, JT Erler
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 99 (6), A36-A36, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–8